LeadXpro and Nuclera partner for complex membrane proteins
Nuclera and leadXpro formed a partnership to combine Nuclera's eProtein Discovery multiplex cell-free screening with leadXpro's AI/ML construct design and cryo-EM expertise, creating an iterative in silico-to-experiment workflow to accelerate structural biology and de-risk membrane protein drug discovery programs.
Why it mattersIntegration of eProtein Discovery and AI/ML-guided cryo-EM workflows lets decision-makers prioritize membrane protein targets faster.